Pfizer and BioNTech updated booster shows strong results against new omicron sublineages in fresh analysis of data
admin A fresh analysis of data on the immune response generated by the bivalent COVID-19 booster…
Read MoreBioNTech
Pfizer and BioNTech report positive data in trial of omicron-targeting bivalent booster in individuals aged 18 and older
Pfizer Inc. PFE, +0.26% and German partner BioNTech SE BNTX, +5.53% said Thursday early data…
Read MorePfizer and BioNTech seek authorization of omicron-targeted booster for children aged 5 to 11
Pfizer and German partner BioNTech said Monday they’re seeking Food and Drug Administration authorization for…
Read MorePfizer and BioNTech seek authorization of omicron-targeted booster for children aged 5 to 11
Pfizer and German partner BioNTech said Monday they’re seeking Food and Drug Administration authorization for…
Read MoreVaccine stocks Pfizer, BioNTech, Moderna and Novavax slide after Biden says pandemic is over
Stocks of the three key vaccine makers fell sharply Monday, after President Joe Biden said…
Read MoreReport finds Americans with long COVID losing billions in wages, as Moderna sues Pfizer and BioNTech over mRNA patents
Some 16 million Americans of working age have long-term COVID and as many as 4…
Read MoreModerna sues Pfizer and BioNTech for patent infringement relating to the mRNA platform used to develop COVID vaccines
Moderna Inc. MRNA, -1.49% said Friday it is suing Pfizer Inc. PFE, -1.06% and German…
Read MoreOmicron-targeting COVID boosters may be out after Labor Day, and Moderna has joined Pfizer and BioNTech in filing for authorization
Americans age 12 and older could begin getting omicron-specific COVID-19 boosters soon after Labor Day,…
Read MorePfizer and BioNTech say data show COVID vaccine has more than 70% efficacy in small children, with cases now rising in just 7 states
Pfizer and German partner BioNTech on Tuesday offered updated COVID vaccine data supporting efficacy in…
Read MoreBioNTech stock sinks more than 8% after profit, revenue fall below expectations
The U.S.-listed shares of Germany-based BioNTech SE BNTX, +1.48% sank 8.2% in premarket trading Monday,…
Read More